May 26, 2020

BREAKING: WHO Suspends Trial Of Hydroxychloroquine As COVID-19 Treatment Over Safety Concerns

May 26, 2020 No Comments





The World Health Organisation has suspended testing malaria drug, Hydroxychloroquine, in COVID-19 patients due to safety concerns.

WHO Director-General, Tedros Adhanom Ghebreyesus, in a virtual press conference on Monday, said the decision came after the publication last week of a study indicating that using the drug on COVID-19 patients could increase their likelihood of dying.





Hydroxycholoroquine has been touted by United States President, Donald Trump, and others as a possible treatment for the disease.  SaharaReporters Media

Trump had said he was taking the drug to help prevent infection.





“The executive group has implemented a temporary pause of the Hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” Ghebreyesus said.

PUBLIC HEALTH Breaking News News AddThis :  Original Author :  Saharareporters, New York Disable advertisements : 

from Latest News https://ift.tt/2zuDg75

0 comments:

Post a Comment

'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();

Site Search